Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-13 10:34 am Sale | 2024-12-31 | 13G | OptimizeRx Corporation OPRX | SAMJO MANAGEMENT, LLC | 50 0.000% | -1,044,750 (-100.00%) | Filing History |
| 2025-02-05 11:41 am Purchase | 2025-02-03 | 13D | OptimizeRx Corporation OPRX | Whetstone Capital Advisors LLC | 1,508,303 8.200% | 1,508,303 (New Position) | Filing History |
| 2025-01-28 12:58 pm Purchase | 2024-12-31 | 13G | OptimizeRx Corporation OPRX | ROYCE & ASSOCIATES LP | 1,069,560 5.810% | 1,069,560 (New Position) | Filing History |
| 2025-01-08 4:37 pm Sale | 2024-12-31 | 13G | OptimizeRx Corporation OPRX | First Light Asset Management, LLC | 0 0.000% | -1,829,074 (Position Closed) | Filing History |
| 2024-12-06 4:26 pm Sale | 2024-11-30 | 13G | OptimizeRx Corporation OPRX | AWM Investment Company Inc. | 878,485 4.800% | -193,347 (-18.04%) | Filing History |
| 2024-11-14 3:18 pm Purchase | 2024-09-30 | 13G | OptimizeRx Corporation OPRX | AWM Investment Company Inc. | 1,071,832 5.900% | 1,071,832 (New Position) | Filing History |
| 2024-11-14 11:25 am Sale | 2024-09-30 | 13G | OptimizeRx Corporation OPRX | Divisadero Street Capital Management, LP | 3,118 0.020% | -946,432 (-99.67%) | Filing History |
| 2024-11-13 10:25 am Purchase | 2024-09-30 | 13G | OptimizeRx Corporation OPRX | SAMJO MANAGEMENT, LLC | 1,044,800 5.700% | 1,044,800 (New Position) | Filing History |
| 2024-06-10 09:00 am Purchase | 2024-05-31 | 13G | OptimizeRx Corporation OPRX | First Light Asset Management, LLC | 1,829,074 10.010% | 100,644 (+5.82%) | Filing History |
| 2024-02-14 5:05 pm Sale | 2023-12-31 | 13G | OptimizeRx Corporation OPRX | First Light Asset Management, LLC | 1,728,430 9.520% | -32,166 (-1.83%) | Filing History |
| 2024-02-13 5:12 pm Sale | 2023-12-29 | 13G | OptimizeRx Corporation OPRX | VANGUARD GROUP INC | 1,021,002 5.620% | -90,409 (-8.13%) | Filing History |
| 2024-01-29 3:26 pm Purchase | 2023-12-31 | 13G | OptimizeRx Corporation OPRX | BlackRock Inc. BLK | 1,134,954 6.300% | 93,216 (+8.95%) | Filing History |
| 2023-12-29 5:30 pm Purchase | 2023-12-22 | 13G | OptimizeRx Corporation OPRX | Divisadero Street Capital Management, LP | 949,550 5.200% | 949,550 (New Position) | Filing History |
| 2023-11-28 4:10 pm Purchase | 2023-10-24 | 13G | OptimizeRx Corporation OPRX | Weintraub Michael | 1,384,467 7.600% | 1,384,467 (New Position) | Filing History |
| 2023-06-09 4:31 pm Purchase | 2023-05-31 | 13G | OptimizeRx Corporation OPRX | First Light Asset Management, LLC | 1,760,596 10.280% | 1,760,596 (New Position) | Filing History |
| 2023-04-06 09:29 am Sale | 2023-03-31 | 13G | OptimizeRx Corporation OPRX | BlackRock Inc. BLK | 1,041,738 6.100% | -1,672,452 (-61.62%) | Filing History |
| 2023-02-09 11:27 am Purchase | 2022-12-30 | 13G | OptimizeRx Corporation OPRX | VANGUARD GROUP INC | 1,111,411 6.480% | 28,635 (+2.64%) | Filing History |
| 2023-01-23 3:52 pm Purchase | 2022-12-31 | 13G | OptimizeRx Corporation OPRX | BlackRock Inc. BLK | 2,714,190 15.800% | 46,102 (+1.73%) | Filing History |
| 2022-02-11 3:42 pm Sale | 2021-12-31 | 13G | OptimizeRx Corporation OPRX | BLAIR WILLIAM & CO | 730,674 4.100% | -49,250 (-6.31%) | Filing History |
| 2022-02-10 08:28 am Purchase | 2021-12-31 | 13G | OptimizeRx Corporation OPRX | VANGUARD GROUP INC | 1,082,776 6.090% | 1,082,776 (New Position) | Filing History |